Commercial Aquaculture Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Report
366 Pages
November 2023
Region: Global
Fairfield Market Research
ID: 5910722

The publisher has published a comprehensive report on the Commercial Aquaculture Vaccines market, forecasting substantial growth in the sector. The global revenue generated from the commercial aquaculture vaccines market was valued at US$ 299 million in 2024. This growth trajectory is expected to drive the market to a valuation of approximately US$ 601 million by the end of 2031.

Driving Factors for Commercial Aquaculture Vaccines Market Growth

Increasing R&D and Development of Novel Vaccines: Leading producers of aquaculture vaccines are well-positioned to leverage rising research and development (R&D) investments to expand their market presence in developing regions, particularly in Africa and Latin America. The Latin American market holds significant potential as localized aquaculture farmers increasingly adopt scientific practices like vaccinations for sustainable farming.

The development of highly stable commercial vaccines with enhanced efficiency and potency, coupled with ongoing incremental innovations, is expected to create new opportunities for global market leaders in commercial aquaculture vaccines. High-income economies such as the U.K. and U.S., which emphasize innovation in zoonotic disease prevention and biotechnological breakthroughs, are poised to provide a conducive environment for the development of commercial aquaculture vaccines.

Challenges Impacting Market Growth

Regulatory Inhibitions and High Commercialization Costs: Regulatory challenges can impede the expansion of the commercial aquaculture vaccines market, particularly when it comes to promoting vaccines internationally. Varied regulatory bodies and procedures across different countries, often influenced by powerful nations with their approval processes, can delay product launches and distribution.

The high commercialization costs associated with aquaculture vaccine production are expected to be a restraining factor. Complex formulations and costly manufacturing processes contribute to elevated production expenses. As a result, some Asian countries tend to avoid vaccinating fish due to the availability of more affordable alternatives, limiting market growth.

Country-wise Insights

Booming U.S. Market: The United States is experiencing market growth driven by innovations in zoonotic disease prevention and treatment, as well as advancements in biotechnology. These factors are expected to create a favorable environment for the development of commercial aquaculture vaccines in high-income economies, contributing to market growth.

Lucrative Norwegian Market: Norway, the largest producer of Atlantic salmon, has significantly reduced the use of antibiotics in salmon farming. This shift has led to a thriving industry, reduced the risk of antibiotic resistance in humans, and positioned Norway as a lucrative market for sales within the global market.

Emerging Japanese Market: Japan's aquaculture industry is vital for sustainable fish production, but infectious diseases pose a significant threat. While Japan has developed efficient vaccines against fish pathogens, there is a need for alternative vaccine methods to address infectious diseases not treatable by traditional inactivated vaccines. Japan's efforts in this regard are driving its emergence as a prominent market for growth.

Competition Landscape

Prominent Market Players:

Zoetis Inc
Merck & Co. Inc (MSD Animal Health/Intervet International B.V.)
HIPRA
Elanco Animal Health Inc
Veterquimica SA
Ictyogroup
Tecnovax
Nisseiken Co., Ltd

Key Segments Covered in Commercial Aquaculture Vaccines Industry Research

Vaccine:

Inactivated
Attenuated
Subunit
DNA

Pathogen:

Bacteria
Virus

Species:

Salmon
Tilapia
Trout
Sea Bass
Carp
Turbot
Bream
Others

Route of Administration:

Intraperitoneal
Intramuscular
Immersion
Oral

End User:

Fish Farming Companies
Fish Veterinary Clinics
Aquatic Research Institute

Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa

This product will be delivered within 1-3 business days.

1. Executive Summary

1.1. Global Commercial Aquaculture Vaccines Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global Commercial Aquaculture Vaccines Market Outlook, 2018 - 2031

3.1. Global Commercial Aquaculture Vaccines Market Outlook, by Vaccine, Value (US$ Mn), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. Inactivated
3.1.1.2. Attenuated
3.1.1.3. Subunit
3.1.1.4. DNA
3.2. Global Commercial Aquaculture Vaccines Market Outlook, by Pathogen, Value (US$ Mn), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. Bacteria
3.2.1.2. Virus
3.3. Global Commercial Aquaculture Vaccines Market Outlook, by Species, Value (US$ Mn), 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. Salmon
3.3.1.2. Tilapia
3.3.1.3. Trout
3.3.1.4. Sea Bass
3.3.1.5. Carp
3.3.1.6. Turbot
3.3.1.7. Bream
3.3.1.8. Others
3.4. Global Commercial Aquaculture Vaccines Market Outlook, by Route of Administration, Value (US$ Mn), 2018 - 2031
3.4.1. Key Highlights
3.4.1.1. Intraperitoneal
3.4.1.2. Intramuscular
3.4.1.3. Immersion
3.4.1.4. Oral
3.5. Global Commercial Aquaculture Vaccines Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
3.5.1. Key Highlights
3.5.1.1. Fish Farming Companies
3.5.1.2. Fish Veterinary Clinics
3.5.1.3. Aquatic Research Institute
3.6. Global Commercial Aquaculture Vaccines Market Outlook, by Region, Value (US$ Mn), 2018 - 2031
3.6.1. Key Highlights
3.6.1.1. North America
3.6.1.2. Europe
3.6.1.3. Asia Pacific
3.6.1.4. Latin America
3.6.1.5. Middle East & Africa

4. North America Commercial Aquaculture Vaccines Market Outlook, 2018 - 2031

4.1. North America Commercial Aquaculture Vaccines Market Outlook, by Vaccine, Value (US$ Mn), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. Inactivated
4.1.1.2. Attenuated
4.1.1.3. Subunit
4.1.1.4. DNA
4.2. North America Commercial Aquaculture Vaccines Market Outlook, by Pathogen, Value (US$ Mn), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Bacteria
4.2.1.2. Virus
4.3. North America Commercial Aquaculture Vaccines Market Outlook, by Species, Value (US$ Mn), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. Salmon
4.3.1.2. Tilapia
4.3.1.3. Trout
4.3.1.4. Sea Bass
4.3.1.5. Carp
4.3.1.6. Turbot
4.3.1.7. Bream
4.3.1.8. Others
4.4. North America Commercial Aquaculture Vaccines Market Outlook, by Route of Administration, Value (US$ Mn), 2018 - 2031
4.4.1. Key Highlights
4.4.1.1. Intraperitoneal
4.4.1.2. Intramuscular
4.4.1.3. Immersion
4.4.1.4. Oral
4.5. North America Commercial Aquaculture Vaccines Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
4.5.1. Key Highlights
4.5.1.1. Fish Farming Companies
4.5.1.2. Fish Veterinary Clinics
4.5.1.3. Aquatic Research Institute
4.5.2. BPS Analysis/Market Attractiveness Analysis
4.6. North America Commercial Aquaculture Vaccines Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
4.6.1. Key Highlights
4.6.1.1. U.S. Commercial Aquaculture Vaccines Market by Vaccine, Value (US$ Mn), 2018 - 2031
4.6.1.2. U.S. Commercial Aquaculture Vaccines Market by Pathogen, Value (US$ Mn), 2018 - 2031
4.6.1.3. U.S. Commercial Aquaculture Vaccines Market by Species, Value (US$ Mn), 2018 - 2031
4.6.1.4. U.S. Commercial Aquaculture Vaccines Market by Route of Administration, Value (US$ Mn), 2018 - 2031
4.6.1.5. U.S. Commercial Aquaculture Vaccines Market by End User, Value (US$ Mn), 2018 - 2031
4.6.1.6. Canada Commercial Aquaculture Vaccines Market by Vaccine, Value (US$ Mn), 2018 - 2031
4.6.1.7. Canada Commercial Aquaculture Vaccines Market by Pathogen, Value (US$ Mn), 2018 - 2031
4.6.1.8. Canada Commercial Aquaculture Vaccines Market by Species, Value (US$ Mn), 2018 - 2031
4.6.1.9. Canada Commercial Aquaculture Vaccines Market by Route of Administration, Value (US$ Mn), 2018 - 2031
4.6.1.10. Canada Commercial Aquaculture Vaccines Market by End User, Value (US$ Mn), 2018 - 2031
4.6.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Commercial Aquaculture Vaccines Market Outlook, 2018 - 2031

5.1. Europe Commercial Aquaculture Vaccines Market Outlook, by Vaccine, Value (US$ Mn), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Inactivated
5.1.1.2. Attenuated
5.1.1.3. Subunit
5.1.1.4. DNA
5.2. Europe Commercial Aquaculture Vaccines Market Outlook, by Pathogen, Value (US$ Mn), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Bacteria
5.2.1.2. Virus
5.3. Europe Commercial Aquaculture Vaccines Market Outlook, by Species, Value (US$ Mn), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Salmon
5.3.1.2. Tilapia
5.3.1.3. Trout
5.3.1.4. Sea Bass
5.3.1.5. Carp
5.3.1.6. Turbot
5.3.1.7. Bream
5.3.1.8. Others
5.4. Europe Commercial Aquaculture Vaccines Market Outlook, by Route of Administration, Value (US$ Mn), 2018 - 2031
5.4.1. Key Highlights
5.4.1.1. Intraperitoneal
5.4.1.2. Intramuscular
5.4.1.3. Immersion
5.4.1.4. Oral
5.5. Europe Commercial Aquaculture Vaccines Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
5.5.1. Key Highlights
5.5.1.1. Fish Farming Companies
5.5.1.2. Fish Veterinary Clinics
5.5.1.3. Aquatic Research Institute
5.5.2. BPS Analysis/Market Attractiveness Analysis
5.6. Europe Commercial Aquaculture Vaccines Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
5.6.1. Key Highlights
5.6.1.1. Germany Commercial Aquaculture Vaccines Market by Vaccine, Value (US$ Mn), 2018 - 2031
5.6.1.2. Germany Commercial Aquaculture Vaccines Market by Pathogen, Value (US$ Mn), 2018 - 2031
5.6.1.3. Germany Commercial Aquaculture Vaccines Market by Species, Value (US$ Mn), 2018 - 2031
5.6.1.4. Germany Commercial Aquaculture Vaccines Market by Route of Administration, Value (US$ Mn), 2018 - 2031
5.6.1.5. Germany Commercial Aquaculture Vaccines Market by End User, Value (US$ Mn), 2018 - 2031
5.6.1.6. U.K. Commercial Aquaculture Vaccines Market by Vaccine, Value (US$ Mn), 2018 - 2031
5.6.1.7. U.K. Commercial Aquaculture Vaccines Market by Pathogen, Value (US$ Mn), 2018 - 2031
5.6.1.8. U.K. Commercial Aquaculture Vaccines Market by Species, Value (US$ Mn), 2018 - 2031
5.6.1.9. U.K. Commercial Aquaculture Vaccines Market by Route of Administration, Value (US$ Mn), 2018 - 2031
5.6.1.10. U.K. Commercial Aquaculture Vaccines Market by End User, Value (US$ Mn), 2018 - 2031
5.6.1.11. France Commercial Aquaculture Vaccines Market by Vaccine, Value (US$ Mn), 2018 - 2031
5.6.1.12. France Commercial Aquaculture Vaccines Market by Pathogen, Value (US$ Mn), 2018 - 2031
5.6.1.13. France Commercial Aquaculture Vaccines Market by Species, Value (US$ Mn), 2018 - 2031
5.6.1.14. France Commercial Aquaculture Vaccines Market by Route of Administration, Value (US$ Mn), 2018 - 2031
5.6.1.15. France Commercial Aquaculture Vaccines Market by End User, Value (US$ Mn), 2018 - 2031
5.6.1.16. Italy Commercial Aquaculture Vaccines Market by Vaccine, Value (US$ Mn), 2018 - 2031
5.6.1.17. Italy Commercial Aquaculture Vaccines Market by Pathogen, Value (US$ Mn), 2018 - 2031
5.6.1.18. Italy Commercial Aquaculture Vaccines Market by Species, Value (US$ Mn), 2018 - 2031
5.6.1.19. Italy Commercial Aquaculture Vaccines Market by Route of Administration, Value (US$ Mn), 2018 - 2031
5.6.1.20. Italy Commercial Aquaculture Vaccines Market by End User, Value (US$ Mn), 2018 - 2031
5.6.1.21. Turkey Commercial Aquaculture Vaccines Market by Vaccine, Value (US$ Mn), 2018 - 2031
5.6.1.22. Turkey Commercial Aquaculture Vaccines Market by Pathogen, Value (US$ Mn), 2018 - 2031
5.6.1.23. Turkey Commercial Aquaculture Vaccines Market by Species, Value (US$ Mn), 2018 - 2031
5.6.1.24. Turkey Commercial Aquaculture Vaccines Market by Route of Administration, Value (US$ Mn), 2018 - 2031
5.6.1.25. Turkey Commercial Aquaculture Vaccines Market by End User, Value (US$ Mn), 2018 - 2031
5.6.1.26. Russia Commercial Aquaculture Vaccines Market by Vaccine, Value (US$ Mn), 2018 - 2031
5.6.1.27. Russia Commercial Aquaculture Vaccines Market by Pathogen, Value (US$ Mn), 2018 - 2031
5.6.1.28. Russia Commercial Aquaculture Vaccines Market by Species, Value (US$ Mn), 2018 - 2031
5.6.1.29. Russia Commercial Aquaculture Vaccines Market by Route of Administration, Value (US$ Mn), 2018 - 2031
5.6.1.30. Russia Commercial Aquaculture Vaccines Market by End User, Value (US$ Mn), 2018 - 2031
5.6.1.31. Rest of Europe Commercial Aquaculture Vaccines Market by Vaccine, Value (US$ Mn), 2018 - 2031
5.6.1.32. Rest of Europe Commercial Aquaculture Vaccines Market by Pathogen, Value (US$ Mn), 2018 - 2031
5.6.1.33. Rest of Europe Commercial Aquaculture Vaccines Market by Species, Value (US$ Mn), 2018 - 2031
5.6.1.34. Rest of Europe Commercial Aquaculture Vaccines Market by Route of Administration, Value (US$ Mn), 2018 - 2031
5.6.1.35. Rest of Europe Commercial Aquaculture Vaccines Market by End User, Value (US$ Mn), 2018 - 2031
5.6.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Commercial Aquaculture Vaccines Market Outlook, 2018 - 2031

6.1. Asia Pacific Commercial Aquaculture Vaccines Market Outlook, by Vaccine, Value (US$ Mn), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Inactivated
6.1.1.2. Attenuated
6.1.1.3. Subunit
6.1.1.4. DNA
6.2. Asia Pacific Commercial Aquaculture Vaccines Market Outlook, by Pathogen, Value (US$ Mn), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Bacteria
6.2.1.2. Virus
6.3. Asia Pacific Commercial Aquaculture Vaccines Market Outlook, by Species, Value (US$ Mn), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. Salmon
6.3.1.2. Tilapia
6.3.1.3. Trout
6.3.1.4. Sea Bass
6.3.1.5. Carp
6.3.1.6. Turbot
6.3.1.7. Bream
6.3.1.8. Others
6.4. Asia Pacific Commercial Aquaculture Vaccines Market Outlook, by Route of Administration, Value (US$ Mn), 2018 - 2031
6.4.1. Key Highlights
6.4.1.1. Intraperitoneal
6.4.1.2. Intramuscular
6.4.1.3. Immersion
6.4.1.4. Oral
6.5. Asia Pacific Commercial Aquaculture Vaccines Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
6.5.1. Key Highlights
6.5.1.1. Fish Farming Companies
6.5.1.2. Fish Veterinary Clinics
6.5.1.3. Aquatic Research Institute
6.5.2. BPS Analysis/Market Attractiveness Analysis
6.6. Asia Pacific Commercial Aquaculture Vaccines Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
6.6.1. Key Highlights
6.6.1.1. China Commercial Aquaculture Vaccines Market by Vaccine, Value (US$ Mn), 2018 - 2031
6.6.1.2. China Commercial Aquaculture Vaccines Market by Pathogen, Value (US$ Mn), 2018 - 2031
6.6.1.3. China Commercial Aquaculture Vaccines Market by Species, Value (US$ Mn), 2018 - 2031
6.6.1.4. China Commercial Aquaculture Vaccines Market by Route of Administration, Value (US$ Mn), 2018 - 2031
6.6.1.5. China Commercial Aquaculture Vaccines Market by End User, Value (US$ Mn), 2018 - 2031
6.6.1.6. Japan Commercial Aquaculture Vaccines Market by Vaccine, Value (US$ Mn), 2018 - 2031
6.6.1.7. Japan Commercial Aquaculture Vaccines Market by Pathogen, Value (US$ Mn), 2018 - 2031
6.6.1.8. Japan Commercial Aquaculture Vaccines Market by Species, Value (US$ Mn), 2018 - 2031
6.6.1.9. Japan Commercial Aquaculture Vaccines Market by Route of Administration, Value (US$ Mn), 2018 - 2031
6.6.1.10. Japan Commercial Aquaculture Vaccines Market by End User, Value (US$ Mn), 2018 - 2031
6.6.1.11. South Korea Commercial Aquaculture Vaccines Market by Vaccine, Value (US$ Mn), 2018 - 2031
6.6.1.12. South Korea Commercial Aquaculture Vaccines Market by Pathogen, Value (US$ Mn), 2018 - 2031
6.6.1.13. South Korea Commercial Aquaculture Vaccines Market by Species, Value (US$ Mn), 2018 - 2031
6.6.1.14. South Korea Commercial Aquaculture Vaccines Market by Route of Administration, Value (US$ Mn), 2018 - 2031
6.6.1.15. South Korea Commercial Aquaculture Vaccines Market by End User, Value (US$ Mn), 2018 - 2031
6.6.1.16. India Commercial Aquaculture Vaccines Market by Vaccine, Value (US$ Mn), 2018 - 2031
6.6.1.17. India Commercial Aquaculture Vaccines Market by Pathogen, Value (US$ Mn), 2018 - 2031
6.6.1.18. India Commercial Aquaculture Vaccines Market by Species, Value (US$ Mn), 2018 - 2031
6.6.1.19. India Commercial Aquaculture Vaccines Market by Route of Administration, Value (US$ Mn), 2018 - 2031
6.6.1.20. India Commercial Aquaculture Vaccines Market by End User, Value (US$ Mn), 2018 - 2031
6.6.1.21. Southeast Asia Commercial Aquaculture Vaccines Market by Vaccine, Value (US$ Mn), 2018 - 2031
6.6.1.22. Southeast Asia Commercial Aquaculture Vaccines Market by Pathogen, Value (US$ Mn), 2018 - 2031
6.6.1.23. Southeast Asia Commercial Aquaculture Vaccines Market by Species, Value (US$ Mn), 2018 - 2031
6.6.1.24. Southeast Asia Commercial Aquaculture Vaccines Market by Route of Administration, Value (US$ Mn), 2018 - 2031
6.6.1.25. Southeast Asia Commercial Aquaculture Vaccines Market by End User, Value (US$ Mn), 2018 - 2031
6.6.1.26. Rest of Asia Pacific Commercial Aquaculture Vaccines Market by Vaccine, Value (US$ Mn), 2018 - 2031
6.6.1.27. Rest of Asia Pacific Commercial Aquaculture Vaccines Market by Pathogen, Value (US$ Mn), 2018 - 2031
6.6.1.28. Rest of Asia Pacific Commercial Aquaculture Vaccines Market by Species, Value (US$ Mn), 2018 - 2031
6.6.1.29. Rest of Asia Pacific Commercial Aquaculture Vaccines Market by Route of Administration, Value (US$ Mn), 2018 - 2031
6.6.1.30. Rest of Asia Pacific Commercial Aquaculture Vaccines Market by End User, Value (US$ Mn), 2018 - 2031
6.6.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Commercial Aquaculture Vaccines Market Outlook, 2018 - 2031

7.1. Latin America Commercial Aquaculture Vaccines Market Outlook, by Vaccine, Value (US$ Mn), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Inactivated
7.1.1.2. Attenuated
7.1.1.3. Subunit
7.1.1.4. DNA
7.2. Latin America Commercial Aquaculture Vaccines Market Outlook, by Pathogen, Value (US$ Mn), 2018 - 2031
7.2.1.1. Bacteria
7.2.1.2. Virus
7.3. Latin America Commercial Aquaculture Vaccines Market Outlook, by Species, Value (US$ Mn), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Salmon
7.3.1.2. Tilapia
7.3.1.3. Trout
7.3.1.4. Sea Bass
7.3.1.5. Carp
7.3.1.6. Turbot
7.3.1.7. Bream
7.3.1.8. Others
7.4. Latin America Commercial Aquaculture Vaccines Market Outlook, by Route of Administration, Value (US$ Mn), 2018 - 2031
7.4.1. Key Highlights
7.4.1.1. Intraperitoneal
7.4.1.2. Intramuscular
7.4.1.3. Immersion
7.4.1.4. Oral
7.5. Latin America Commercial Aquaculture Vaccines Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
7.5.1. Key Highlights
7.5.1.1. Fish Farming Companies
7.5.1.2. Fish Veterinary Clinics
7.5.1.3. Aquatic Research Institute
7.5.2. BPS Analysis/Market Attractiveness Analysis
7.6. Latin America Commercial Aquaculture Vaccines Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
7.6.1. Key Highlights
7.6.1.1. Brazil Commercial Aquaculture Vaccines Market by Vaccine, Value (US$ Mn), 2018 - 2031
7.6.1.2. Brazil Commercial Aquaculture Vaccines Market by Pathogen, Value (US$ Mn), 2018 - 2031
7.6.1.3. Brazil Commercial Aquaculture Vaccines Market by Species, Value (US$ Mn), 2018 - 2031
7.6.1.4. Brazil Commercial Aquaculture Vaccines Market by Route of Administration, Value (US$ Mn), 2018 - 2031
7.6.1.5. Brazil Commercial Aquaculture Vaccines Market by End User, Value (US$ Mn), 2018 - 2031
7.6.1.6. Mexico Commercial Aquaculture Vaccines Market by Vaccine, Value (US$ Mn), 2018 - 2031
7.6.1.7. Mexico Commercial Aquaculture Vaccines Market by Pathogen, Value (US$ Mn), 2018 - 2031
7.6.1.8. Mexico Commercial Aquaculture Vaccines Market by Species, Value (US$ Mn), 2018 - 2031
7.6.1.9. Mexico Commercial Aquaculture Vaccines Market by Route of Administration, Value (US$ Mn), 2018 - 2031
7.6.1.10. Mexico Commercial Aquaculture Vaccines Market by End User, Value (US$ Mn), 2018 - 2031
7.6.1.11. Argentina Commercial Aquaculture Vaccines Market by Vaccine, Value (US$ Mn), 2018 - 2031
7.6.1.12. Argentina Commercial Aquaculture Vaccines Market by Pathogen, Value (US$ Mn), 2018 - 2031
7.6.1.13. Argentina Commercial Aquaculture Vaccines Market by Species, Value (US$ Mn), 2018 - 2031
7.6.1.14. Argentina Commercial Aquaculture Vaccines Market by Route of Administration, Value (US$ Mn), 2018 - 2031
7.6.1.15. Argentina Commercial Aquaculture Vaccines Market by End User, Value (US$ Mn), 2018 - 2031
7.6.1.16. Rest of Latin America Commercial Aquaculture Vaccines Market by Vaccine, Value (US$ Mn), 2018 - 2031
7.6.1.17. Rest of Latin America Commercial Aquaculture Vaccines Market by Pathogen, Value (US$ Mn), 2018 - 2031
7.6.1.18. Rest of Latin America Commercial Aquaculture Vaccines Market by Species, Value (US$ Mn), 2018 - 2031
7.6.1.19. Rest of Latin America Commercial Aquaculture Vaccines Market by Route of Administration, Value (US$ Mn), 2018 - 2031
7.6.1.20. Rest of Latin America Commercial Aquaculture Vaccines Market by End User, Value (US$ Mn), 2018 - 2031
7.6.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Commercial Aquaculture Vaccines Market Outlook, 2018 - 2031

8.1. Middle East & Africa Commercial Aquaculture Vaccines Market Outlook, by Vaccine, Value (US$ Mn), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Inactivated
8.1.1.2. Attenuated
8.1.1.3. Subunit
8.1.1.4. DNA
8.2. Middle East & Africa Commercial Aquaculture Vaccines Market Outlook, by Pathogen, Value (US$ Mn), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Bacteria
8.2.1.2. Virus
8.3. Middle East & Africa Commercial Aquaculture Vaccines Market Outlook, by Species, Value (US$ Mn), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. Salmon
8.3.1.2. Tilapia
8.3.1.3. Trout
8.3.1.4. Sea Bass
8.3.1.5. Carp
8.3.1.6. Turbot
8.3.1.7. Bream
8.3.1.8. Others
8.4. Middle East & Africa Commercial Aquaculture Vaccines Market Outlook, by Route of Administration, Value (US$ Mn), 2018 - 2031
8.4.1. Key Highlights
8.4.1.1. Intraperitoneal
8.4.1.2. Intramuscular
8.4.1.3. Immersion
8.4.1.4. Oral
8.5. Middle East & Africa Commercial Aquaculture Vaccines Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
8.5.1. Key Highlights
8.5.1.1. Fish Farming Companies
8.5.1.2. Fish Veterinary Clinics
8.5.1.3. Aquatic Research Institute
8.5.2. BPS Analysis/Market Attractiveness Analysis
8.6. Middle East & Africa Commercial Aquaculture Vaccines Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
8.6.1. Key Highlights
8.6.1.1. GCC Commercial Aquaculture Vaccines Market by Vaccine, Value (US$ Mn), 2018 - 2031
8.6.1.2. GCC Commercial Aquaculture Vaccines Market by Pathogen, Value (US$ Mn), 2018 - 2031
8.6.1.3. GCC Commercial Aquaculture Vaccines Market by Species, Value (US$ Mn), 2018 - 2031
8.6.1.4. GCC Commercial Aquaculture Vaccines Market by Route of Administration, Value (US$ Mn), 2018 - 2031
8.6.1.5. GCC Commercial Aquaculture Vaccines Market by End User, Value (US$ Mn), 2018 - 2031
8.6.1.6. South Africa Commercial Aquaculture Vaccines Market by Vaccine, Value (US$ Mn), 2018 - 2031
8.6.1.7. South Africa Commercial Aquaculture Vaccines Market by Pathogen, Value (US$ Mn), 2018 - 2031
8.6.1.8. South Africa Commercial Aquaculture Vaccines Market by Species, Value (US$ Mn), 2018 - 2031
8.6.1.9. South Africa Commercial Aquaculture Vaccines Market by Route of Administration, Value (US$ Mn), 2018 - 2031
8.6.1.10. South Africa Commercial Aquaculture Vaccines Market by End User, Value (US$ Mn), 2018 - 2031
8.6.1.11. Egypt Commercial Aquaculture Vaccines Market by Vaccine, Value (US$ Mn), 2018 - 2031
8.6.1.12. Egypt Commercial Aquaculture Vaccines Market by Pathogen, Value (US$ Mn), 2018 - 2031
8.6.1.13. Egypt Commercial Aquaculture Vaccines Market by Species, Value (US$ Mn), 2018 - 2031
8.6.1.14. Egypt Commercial Aquaculture Vaccines Market by Route of Administration, Value (US$ Mn), 2018 - 2031
8.6.1.15. Egypt Commercial Aquaculture Vaccines Market by End User, Value (US$ Mn), 2018 - 2031
8.6.1.16. Nigeria Commercial Aquaculture Vaccines Market by Vaccine, Value (US$ Mn), 2018 - 2031
8.6.1.17. Nigeria Commercial Aquaculture Vaccines Market by Pathogen, Value (US$ Mn), 2018 - 2031
8.6.1.18. Nigeria Commercial Aquaculture Vaccines Market by Species, Value (US$ Mn), 2018 - 2031
8.6.1.19. Nigeria Commercial Aquaculture Vaccines Market by Route of Administration, Value (US$ Mn), 2018 - 2031
8.6.1.20. Nigeria Commercial Aquaculture Vaccines Market by End User, Value (US$ Mn), 2018 - 2031
8.6.1.21. Rest of Middle East & Africa Commercial Aquaculture Vaccines Market by Vaccine, Value (US$ Mn), 2018 - 2031
8.6.1.22. Rest of Middle East & Africa Commercial Aquaculture Vaccines Market by Pathogen, Value (US$ Mn), 2018 - 2031
8.6.1.23. Rest of Middle East & Africa Commercial Aquaculture Vaccines Market by Species, Value (US$ Mn), 2018 - 2031
8.6.1.24. Rest of Middle East & Africa Commercial Aquaculture Vaccines Market by Route of Administration, Value (US$ Mn), 2018 - 2031
8.6.1.25. Rest of Middle East & Africa Commercial Aquaculture Vaccines Market by End User, Value (US$ Mn), 2018 - 2031
8.6.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. By Species vs by Pathogen Heat map
9.2. Manufacturer vs by Pathogen Heat map
9.3. Company Market Share Analysis, 2023
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. Zoetis Inc.
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. Merck & Co. Inc. (MSD Animal Health/Intervet International B.V.)
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. HIPRA
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. Elanco Animal Health Inc.
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. Veterquimica SA
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. Ictyogroup
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. Tecnovax
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. Nisseiken Co., Ltd.
9.5.8.1. Company Overview
9.5.8.2. Product Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Zoetis Inc.
Merck & Co. Inc. (MSD Animal Health/Intervet International B.V.)
HIPRA
Elanco Animal Health Inc.
Veterquimica SA
Ictyogroup
Tecnovax
Nisseiken Co., Ltd.

Methodology

LOADING...

Driving Factors for Commercial Aquaculture Vaccines Market Growth

Challenges Impacting Market Growth

Country-wise Insights

Competition Landscape

Prominent Market Players:

Key Segments Covered in Commercial Aquaculture Vaccines Industry Research

Vaccine:

Pathogen:

Species:

Route of Administration:

End User:

Region:

Table of Contents

Companies Mentioned (Partial List)

Methodology

Related Topics

Related Reports

Global Aquaculture Vaccines Market by Type (DNA Vaccines, Inactivated Vaccines, Live Attenuated Vaccines), Product (DNA Vaccines, Inactivated Vaccines), Route of Administration, Application, End-User - Forecast 2024-2030

Global Aquaculture Vaccines Market Analysis & Forecast to 2024-2034: Market By Product; By Route Of Administration; By Application; and By Region

Autogenous Vaccine For Aquaculture Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Fish Vaccine Market Size and Forecasts 2020-2030, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Vaccine Type, Application, Route of Administration, Species, and Geography

Mediterranean Fish Vaccine Market Forecast to 2030 - Regional Analysis by Vaccine Type, Route of Administration, Species, and Country